Anti-N<sub>form</sub> Antibody in Hemodialysis Patients

Yee-Yung Ng(Pediatric Nephrology of Alabama), Mo‐Ping Chow(Taipei Veterans General Hospital), Shiao-Chi Wu(National Defense Medical Center), Jau-Yi Lyou(Taipei Veterans General Hospital), David C.H. Harris(Westmead Hospital), Tung-Po Huang(Pediatric Nephrology of Alabama)
American Journal of Nephrology
January 1, 1995
Cited by 12

Abstract

The anti-Nform antibody is produced by dialysis patients following reuse of dialyzers sterilized with formaldehyde and it has been implicated as a cause of hemolytic anemia. Formaldehyde is one of the common disinfectants used for reprocessing capillary hemodialyzers. The safety of formaldehyde and the clinical significance of anti-Nform antibody need further evaluation. Amongst 45 patients practising dialyzer reuse, anti-Nform antibody was detected in 5 (11.1%), but not amongst 111 patients not reusing their dialyzer (p < 0.005). The presence of anti-Nform was not related to the sex, or duration of dialysis with and without dialyzer reuse. There was no overt hemolysis in the patients with positive anti-Nf0rm antibody. Direct Coombs’ test was positive amongst 80% of all tested patients with anti-Nform antibody, and in 38% of patients reusing dialyzers but without anti-Nform antibody. No tests of hemolysis (including direct Coombs’ test) discriminated between anti-Nform antibody-positive and -negative patients, nor between anti-Nform antibody patients with and without overt hemolysis. The best diagnostic test for hemolysis in anti-Nform antibody-positive patients was hematocrit rise after cessation of dialyzer reuse. It appears that despite the induction of anti-Nform antibody, hemolysis is rarely a serious consequence of dialyzer reuse.


Related Papers

No related papers found

Powered by citation graph analysis